NanoPhoria vs TIXiMED
NanoPhoria vs TIXiMED, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: NanoPhoria is on 23/100 and TIXiMED on 49/100.
Where each one leads
NanoPhoria
- funding raised: $83.5M against $4.8M
TIXiMED
- our overall score: 49/100 against 23/100
At a glance
| Measure | NanoPhoria | TIXiMED |
|---|---|---|
| What it is | Developing inhalable therapies for cardiovascular diseases using a proprietary nanoparticle platform. | Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders. |
| Category | Biotechnology, Healthcare, Pharmaceuticals, Medical Devices | Biotechnology, Pharmaceuticals, HealthTech, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | Not published | 2021 |
| Headquarters | Italy | Birmingham, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | NanoPhoria | TIXiMED |
|---|---|---|
| Employees | Not published | 5 |
| Total funding | $83.5M | $4.8M |
| Latest round | null | Seed |
| Valuation | Not published | $1.1B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | NanoPhoria | TIXiMED |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 23/100 | 49/100 |
| Traction | 40/100 | 41/100 |
| Team | Not published | 60/100 |
| Community | 10/100 | Not published |
| Search visibility | 2/100 | 5/100 |
| Quality | 25/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | D (55/100) |
| Domain ratingLink authority, 0-100 | Not published | 4/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | NanoPhoria | TIXiMED |
|---|---|---|
| Hosting | Not detected | Google Cloud |
NanoPhoria vs TIXiMED: common questions
Which is better, NanoPhoria or TIXiMED?
On our 0-100 score TIXiMED rates higher (49/100 against 23/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do NanoPhoria and TIXiMED compare on the numbers?
NanoPhoria leads on funding raised ($83.5M against $4.8M). TIXiMED leads on our overall score (49/100 against 23/100).
Read the full NanoPhoria review and pricing or the TIXiMED review and pricing. You can also browse other NanoPhoria alternatives we track.